Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
98.93
-1.95 (-1.93%)
May 21, 2026, 11:31 AM EDT - Market open
Protagonist Therapeutics Analyst Ratings
Total Analysts
12
Consensus Rating
Strong Buy
Price Target
$112.62
Upside
+13.84%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Buy Maintains $120 → $137 | Buy | Maintains | $120 → $137 | +38.48% | May 6, 2026 |
| Wedbush | Wedbush | Buy Maintains $112 → $118 | Buy | Maintains | $112 → $118 | +19.28% | May 6, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $110 → $121 | Strong Buy | Maintains | $110 → $121 | +22.31% | Apr 15, 2026 |
| Clear Street | Clear Street | Strong Buy Maintains $104 → $116 | Strong Buy | Maintains | $104 → $116 | +17.25% | Apr 7, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $107 → $110 | Buy | Maintains | $107 → $110 | +11.19% | Mar 19, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $95 → $106 | Buy | Maintains | $95 → $106 | +7.15% | Mar 19, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $115 → $125 | Strong Buy | Maintains | $115 → $125 | +26.35% | Mar 19, 2026 |
| Barclays | Barclays | Buy Maintains $113 → $119 | Buy | Maintains | $113 → $119 | +20.29% | Mar 19, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $65 → $95 | Hold | Maintains | $65 → $95 | -3.97% | Mar 3, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $90 → $100 | Strong Buy | Maintains | $90 → $100 | +1.08% | Feb 26, 2026 |
| Barclays | Barclays | Buy Maintains $108 → $113 | Buy | Maintains | $108 → $113 | +14.22% | Feb 26, 2026 |
| Citizens | Citizens | Buy Maintains $102 → $112 | Buy | Maintains | $102 → $112 | +13.21% | Feb 26, 2026 |
| Jefferies | Jefferies | Strong Buy Maintains $95 → $118 | Strong Buy | Maintains | $95 → $118 | +19.28% | Feb 2, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $117 | Strong Buy | Maintains | $80 → $117 | +18.27% | Jan 30, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $88 → $110 | Strong Buy | Maintains | $88 → $110 | +11.19% | Jan 5, 2026 |
| Barclays | Barclays | Buy Maintains $88 → $108 | Buy | Maintains | $88 → $108 | +9.17% | Dec 17, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.